Tweaking antibody could lead to vaccine against HIV
May 8th, 2011 - 2:21 pm ICT by IANSSydney, May 8 (IANS) The HIV virus is a “slippery customer” and always tries to evade the effect of human antibodies, say researchers who suggest that tweaking an antibody could help develop an effective vaccine against HIV.
Researchers were able to identify how the HIV virus evolves to evade or ‘escape’ the effect of human antibodies like the ADCC, or antibody-dependent cell-mediated cytotoxicity. ADCC is an immune response in which antibodies, by coating target cells, makes them vulnerable to attack by immune cells.
Study co-author Stephen Kent, professor at the University of Melbourne, said ADCC antibodies have been strongly implicated in protection from HIV in several trials, but their action was poorly understood, reports the journal Proceedings of the National Academy of Sciences.
“These results show what a slippery customer the HIV virus is, but also shows that these ADCC antibodies are really forcing the virus into changing . . . that cause it to be weaker,” he said.
“It also implies that if good ADCC antibodies were available prior to infection, via a vaccine, we might be able to stop the virus taking hold. This is the holy grail,” Kent said, according to a Melbourne statement
The team led by Ivan Stratov and Prof Kent employed a novel technology their lab developed to find where ADCC antibodies were attacking the virus. They then looked at how the sequence of the virus had mutated over time to avoid the immune response.
“There is an urgent need to identify effective immunity to HIV and our studies suggest ADCC responses supply significant immune pressure on the virus,” said Stratov, a clinician and researcher.
The group is now working on designing HIV vaccines to induce ADCC antibodies that make it more difficult for the virus to escape.
- Breast milk antibodies help neutralize HIV - May 23, 2012
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- H1N1 pandemic flu strain 'key to universal vaccine' - Jan 11, 2011
- Vaccine-delivering nanoparticles may help fight HIV, malaria - Feb 23, 2011
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- 'Pep talk' can revive exhausted immune cells: Study - Dec 14, 2011
- Earlier exposure to flu viruses 'makes people immune to current H1N1 influenza' - Oct 15, 2009
- New findings bring scientists closer to an effective HIV vaccine - Jan 15, 2011
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Original HIV infection holds its sway despite numerous changes - Jun 30, 2010
- Unearthing Of Antibodies Could Assist The Discovery Of An AIDS Vaccine - Jul 09, 2010
- Scientists tame HIV by stripping it of cholesterol - Sep 29, 2011
- Promising target for AIDS vaccine identified - Apr 01, 2011
- Biological catch-22 prevents generation of HIV blocking antibodies - Dec 16, 2009
- Universal influenza vaccine 'on the anvil' - Dec 07, 2010
Tags: adcc, antibody, author stephen, clinician, co author, hiv researchers, hiv vaccines, hiv virus, holy grail, human antibodies, immune cells, immune response, journal proceedings, national academy of sciences, novel technology, proceedings of the national academy, proceedings of the national academy of sciences, stephen kent, target cells, university of melbourne